Evidence map›Paper›PMID 41104651›Full record

ArticlemAbs2025

Germline-aware deep learning models and benchmarks for predicting antibody VH-VL pairing.

Sara Joubbi, Enrico D'Arco, Giuseppe Maccari, Paolo Milazzo, Alessio Micheli

Abstract read
In one paragraph

Article in mAbs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sara JoubbiDepartment of Computer Science, University of Pisa, Pisa, Italy.ORCID 0009-0002-1079-7204
Enrico D'ArcoDepartment of Computer Science, University of Pisa, Pisa, Italy.
Giuseppe MaccariData Science for Health Lab, Fondazione Toscana Life Sciences, Siena, Italy.ORCID 0000-0002-2894-3583
Paolo MilazzoDepartment of Computer Science, University of Pisa, Pisa, Italy.ORCID 0000-0002-7309-6424
Alessio MicheliDepartment of Computer Science, University of Pisa, Pisa, Italy.ORCID 0000-0001-5764-5238

Funding

Italian Ministry of Health POS 2014-2020
6 · The paper itself

Abstract

Variable heavy (VH) and variable light (VL) chain pairing is a critical determinant of antibody diversity, stability, and antigen-binding specificity. Identifying productive VH - VL combinations experimentally is labor-intensive and costly, motivating the development of computational methods that can more efficiently predict compatible heavy - light chain pairs. In this work, we present a comprehensive framework that includes a new benchmark dataset and three deep learning models, each trained with a different negative sampling strategy: random pairing, V-gene mismatching, and full V(D)J germline mismatching. Our dataset includes natural pairs and these three types of synthetic negatives to simulate increasingly realistic biological constraints. Furthermore, we present a lightweight yet highly effective BERT-based model that achieves over 90% accuracy in discriminating natural from synthetic VH - VL pairs. Through extensive evaluation, we demonstrate that V(D)J-informed negative sampling significantly improves model generalization and biological interpretability. By providing reproducible baselines and a biologically grounded benchmark, this work lays the foundation for future development of efficient computational tools in antibody engineering.

Indexed as

Deep LearningImmunoglobulin Heavy ChainsImmunoglobulin Light ChainsImmunoglobulin Variable RegionBenchmarkingComputational BiologyHumansImmunoglobulin Heavy ChainsImmunoglobulin Light ChainsImmunoglobulin Variable RegionAntibody language modelsantibody pairingbenchmarkdeep learninggermline

Identifiers

PMID41104651
PMCPMC12536629

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.